BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23133937)

  • 1. [Genetic and chromosomal abnormalities in myelodysplastic syndrome].
    Mitani K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():108-12. PubMed ID: 23133937
    [No Abstract]   [Full Text] [Related]  

  • 2. A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.
    Li X; Xu F; Wu LY; Zhao YS; Guo J; He Q; Zhang Z; Chang CK; Wu D
    Sci Rep; 2020 Jan; 10(1):826. PubMed ID: 31964915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
    Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
    PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome-wide analysis of AML and MDS].
    Ogawa S
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():113-8. PubMed ID: 23133938
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpreting new molecular genetics in myelodysplastic syndromes.
    Abdel-Wahab O; Figueroa ME
    Hematology Am Soc Hematol Educ Program; 2012; 2012():56-64. PubMed ID: 23233561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes: lost between two states?
    Acquaviva C; Gelsi-Boyer V; Birnbaum D
    Leukemia; 2010 Jan; 24(1):1-5. PubMed ID: 20068572
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes.
    Kobbe G; Schroeder T; Rautenberg C; Kaivers J; Gattermann N; Haas R; Germing U
    Expert Rev Hematol; 2019 Oct; 12(10):821-831. PubMed ID: 31322458
    [No Abstract]   [Full Text] [Related]  

  • 8. Unraveling the molecular pathophysiology of myelodysplastic syndromes.
    Bejar R; Levine R; Ebert BL
    J Clin Oncol; 2011 Feb; 29(5):504-15. PubMed ID: 21220588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonal haematopoiesis: A concise review].
    Danlos FX; Papo M; Micol JB
    Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities in myelodysplastic syndromes.
    Nowell PC
    Semin Oncol; 1992 Feb; 19(1):25-33. PubMed ID: 1736367
    [No Abstract]   [Full Text] [Related]  

  • 11. ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts.
    Mauvieux L; Helias C; Perrusson N; Lioure B; Sorel N; Brizard F; Lessard M
    Leukemia; 2004 Aug; 18(8):1436-8. PubMed ID: 15175627
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetics in myeloid malignancies.
    Deneberg S
    Methods Mol Biol; 2012; 863():119-37. PubMed ID: 22359290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic abnormalities in myelodysplastic syndrome].
    Ogawa S
    Rinsho Ketsueki; 2005 Jun; 46(6):439-52. PubMed ID: 16447726
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
    Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic abnormalities in myelodysplastic syndrome.
    Jacobs A
    Cancer Genet Cytogenet; 1991 Oct; 56(1):1-6. PubMed ID: 1747865
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
    Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
    J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Abuhadra N; Mukherjee S; Al-Issa K; Adema V; Hirsch CM; Advani A; Przychodzen B; Makhoul A; Awada H; Maciejewski JP; Sekeres MA; Nazha A
    Leuk Lymphoma; 2019 Jun; 60(6):1587-1590. PubMed ID: 30618304
    [No Abstract]   [Full Text] [Related]  

  • 18. Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
    Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
    Leuk Lymphoma; 2019 Dec; 60(13):3316-3319. PubMed ID: 31204875
    [No Abstract]   [Full Text] [Related]  

  • 19. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
    Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
    Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
    Friedrich C; Gay J; Alary AS; Arlet JB; Socie G; Fremaux-Bacchi V; Weiss IR; Kosmider O; Darnige L
    Ann Hematol; 2020 Oct; 99(10):2459-2461. PubMed ID: 32533252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.